Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ulsan University Hospital, Dong-gu, Ulsan, Republic of Korea

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

M Atiqul Haque, PhD

Bangladesh Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Peter Kertes, MD, FRCSC

Sunnybrook Health Sciences Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Norton Perez, MD

Cooperative University of Colombia

Moderately Similar
3 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Vivian T Yin, MD

University of Toronto

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

David R West, PhD

University of Colorado, Denver

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Robert C Block, MD, MPH

University of Rochester

Moderately Similar
2 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Daniel Weisbrod, MD, FRCSC

Sunnybrook Health Sciences Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Ki Hyeong Lee, MD, Ph.D

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Eunkyung Cho, MD, Ph.D

Gachon University Gil Medical Center, Incheon, Republic of Korea

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Ji-Youn Han, MD. Ph.D

National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea,Asan Medical Center, Songpa-gu, Seoul, Republic of Korea,

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01718847Phase 2PrincipalInvestigator

NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors

Increased Drug Resistance
Completed

All 1 trials loaded